Published in Surg Gynecol Obstet on February 01, 1967
Evolution of liver transplantation. Hepatology (1982) 19.54
Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
Clinical reactions and serologic changes after the administration of heterologous antilymphocyte globulin to human recipients of renal homografts. Ann Intern Med (1968) 2.72
Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. Transplantation (1990) 2.59
Studies of blood flow and ultrastructural changes in rejecting and nonrejecting canine orthotopic liver homografts. Surgery (1968) 2.58
Further experiments on the action of antilymphocytic antiserum. Proc Natl Acad Sci U S A (1967) 2.31
Animal research in liver transplantation with special reference to the dog. Semin Liver Dis (1985) 2.28
Suppression of adjuvant disease in the rat by heterologous antilymphocyte globulin. J Exp Med (1968) 2.27
Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet (1968) 2.23
Transplantation milestones. Viewed with one- and two-way paradigms of tolerance. JAMA (1995) 2.20
FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats. Transplantation (1990) 2.13
Transplantation tolerance from a historical perspective. Nat Rev Immunol (2001) 2.04
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg (2005) 1.93
The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967). J Am Coll Surg (2002) 1.81
Cyclophosphamide and human organ transplantation. Lancet (1971) 1.77
Factors in the Development of Liver Transplantation. Transplant Proc (1985) 1.74
The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg (1996) 1.71
Homotransplantation of the liver. Transplantation (1967) 1.71
Immunosuppression and other nonsurgical factors in the improved results of liver transplantation. Semin Liver Dis (1985) 1.62
Liver transplantation: an unfinished product. Transplant Proc (1989) 1.61
Thoracic duct fistula and renal transplantation. Ann Surg (1979) 1.60
Renal transplantation in the inbred rat. 3. A study of heterologous anti-thymocyte sera. J Exp Med (1967) 1.57
Liver and kidney transplantation in children receiving cyclosporin A and steroids. J Pediatr (1982) 1.54
Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53
Immunofluorescent examination of biopsies from long-term renal allografts. N Engl J Med (1970) 1.53
Effects of heterologous anti-lymphocyte serum on the distribution of 51-Cr-labelled lymph node cells in mice. Immunology (1968) 1.52
A trial with heterologous antilymphocyte globulin in man. Transplant Proc (1969) 1.51
Dissociation of hemolytic and lymphocyte-transforming activities of streptolysin S preparations. J Exp Med (1969) 1.45
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation (2004) 1.43
2,500 living donor kidney transplants: a single-center experience. Ann Surg (2001) 1.41
Anti-serum to cultured human lymphoblasts: preparation, purification and immunosuppressive properties in man. Ann Surg (1969) 1.37
Human renal transplants. 3. Immunopathologic studies. Lab Invest (1970) 1.31
Improvements in the preparation of heterologous antilymphocyte globulin with special reference to absorption and diethylaminoethyl cellulose batch production. Surgery (1969) 1.29
Cadaveric renal transplantation under cyclosporine-steroid therapy. Surg Gynecol Obstet (1983) 1.29
Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors. Ann Surg (1976) 1.26
ORTHOCLONE OKT3 in Treatment of Allografts Rejected Under Cyclosporine-Steroid Therapy. Transplant Proc (1986) 1.25
Body temperature changes during organ transplantation. Anesth Analg (1971) 1.17
Liver transplantation in the ciclosporin era. Prog Allergy (1986) 1.14
The clinical use of antilymphocyte globulin in renal homotransplantation. Transplantation (1967) 1.09
The effect of heterologous anti-lymphocyte seerum on mouse hemopoietic stem cells. J Exp Med (1968) 1.07
Chimerism and tolerance in transplantation. Proc Natl Acad Sci U S A (2004) 1.07
Pediatric liver transplantation. Transplant Proc (1987) 1.03
Liver transplantation: where it's been and where it's going. Gastroenterol Clin North Am (1988) 1.01
Effect of antilymphocyte serum and other immunosuppressive agents on canine jejunal allografts. Ann Surg (1970) 0.99
Themes of liver transplantation. Hepatology (2010) 0.98
Thymectomy and renal homotransplantation. Clin Exp Immunol (1970) 0.98
Acquired immunologic tolerance: with particular reference to transplantation. Immunol Res (2007) 0.97
Current concepts in transplant surgery: liver transplantation today. Langenbecks Arch Surg (2008) 0.96
Prolonged administration of antithymocyte serum in mice. II. Histopathological investigation. Clin Exp Immunol (1971) 0.94
Lessons of organ-induced tolerance learned from historical clinical experience. Transplantation (2004) 0.94
Cardiac transplantation: general considerations and results. Ann Surg (1969) 0.94
The unfinished legacy of liver transplantation: emphasis on immunology. Hepatology (2006) 0.93
Studies on cellular and humoral immune factors in human renal transplantation. Ann Surg (1971) 0.93
Steps in immunosuppression for renal transplantation. Kidney Int Suppl (1983) 0.93
Clinical evaluation of equine antithymocyte globulin in recipients of renal allografts: Analysis of survival, renal function, rejection, histocompatibility, and complications. Ann Surg (1974) 0.92
History of clinical transplantation. World J Surg (2000) 0.91
Historic landmarks in clinical transplantation: conclusions from the consensus conference at the University of California, Los Angeles. World J Surg (2000) 0.90
Combined immunosuppression for canine renal allograft prolongation: antilymphocyte serum plus prednisolone or azathioprine. Ann Surg (1968) 0.86
Monoclonal antibody therapy with ciclosporin and steroids in nonmatched cadaveric renal transplants. Nephron (1987) 0.85
Personal reflections in transplantation. Surg Clin North Am (1978) 0.84
Symposium on immunosuppressive drugs. Attributes of clinically used immunosuppressive drugs: possible future uses of antilymphoid sera. Fed Proc (1967) 0.84
A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes. Transplantation (2015) 0.83
A new liver perfusion and preservation system for transplantation research in large animals. J Invest Surg (1990) 0.83
Therapeutic drug monitoring of immunosuppressant drugs. Br J Clin Pharmacol (1999) 0.83
Selected topics on antilymphocyte serum. Fed Proc (1970) 0.83
Organ transplantation: a practical triumph and epistemologic collapse. Proc Am Philos Soc (2003) 0.82
Modification of established rejection of canine kidney and liver homografts with antilymphocyte gamma-G globulin. Surgery (1969) 0.82
A DEAE-cellulose batch technique for antilymphyocyte globulin preparation. Surg Forum (1968) 0.82
France and the early history of organ transplantation. Perspect Biol Med (1993) 0.82
Prolongation of canine renal allografts by horse anti-dog lymphocyte serum and globulin. Ann Surg (1969) 0.81
The effects of x-irradiation and anti-lymphocyte serum on the responses to tumour allografts. Br J Cancer (1970) 0.80
Experience with Orthoclone OKT3 monoclonal antibody in liver transplantation. Am J Kidney Dis (1988) 0.80
Organ transplantation, past and present. Surg Clin North Am (1968) 0.79
The effect of serum ALG concentrations on results following renal transplantation. Ann Surg (1977) 0.78
Pancreas and islet cell transplantation. Best Pract Res Clin Gastroenterol (2002) 0.78
Liver transplantation. Gastroenterology (1997) 0.78
Production and assay of dog, pig and goat heterologous anti-rabbit lymphocyte serum. Clin Exp Immunol (1973) 0.78
The mystique of organ transplantation. J Am Coll Surg (2005) 0.78
Historical overview of transplantation. Cold Spring Harb Perspect Med (2013) 0.76
THE USE OF HETEROLOGOUS ANTILYMPHOCYTE GLOBULIN (ALG) IN HUMAN RENAL AND LIVER TRANSPLANTATION. Int Congr Ser (1967) 0.76
The birth of clinical organ transplantation. J Am Coll Surg (2001) 0.76
The current status of hepatic transplantation at the University of Pittsburgh. Clin Transpl (1995) 0.76
Monitoring antithymocyte globulin in renal transplantation. Ann R Coll Surg Engl (1996) 0.76
Organ transplantation--then and now. Hosp Physician (1987) 0.75
The development of clinical renal transplantation. Am J Kidney Dis (1990) 0.75
Clinical immunosuppression with antilymphocyte globulin. Can Med Assoc J (1976) 0.75
The present state of liver transplantation and the future prospects for intestinal transplantation. Immunol Invest (1989) 0.75
The transplantation of gastrointestinal organs. Gastroenterology (1993) 0.75
Antilymphocyte serum. Br Med J (1968) 0.75
Alterations in T and B lymphocytes in heart transplant patients early and late postoperatively. J Clin Invest (1976) 0.75
Effects of anti-lymphocytic globulin in human subjects. Immunology (1981) 0.75
Transplantation: the realization of a dream. Semin Nucl Med (1988) 0.75
FACTORS DETERMINING SHORT- AND LONG-TERM SURVIVAL AFTER ORTHOTOPIC LIVER HOMOTRANSPLANTATION IN THE DOG. Surgery (1965) 6.71
The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type. J Exp Med (1961) 6.05
Studies on heterologous anti-lymphocyte serum in mice. I. In vitro and in vivo properties. J Immunol (1966) 5.59
Studies on heterologous anti-lymphocyte serum in mice. II. Effect on the immune response. J Immunol (1966) 4.49
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
THE EFFECT OF LYMPHOCYTE DEPLETION BY THORACIC DUCT FISTULA AND ADMINISTRATION OF ANTILYMPHOCYTIC SERUM ON THE SURVIVAL OF SKIN HOMOGRAFTS IN RATS. Ann N Y Acad Sci (1964) 3.79
EFFECT OF LYMPHOCYTE DEPLETION BY THORACIC DUCT FISTULA AND ADMINISTRATION OF ANTILYMPHOCYTIC SERUM ON THE SURVIVAL OF SKIN HOMOGRAFTS IN RATS. Nature (1963) 3.65
Immunological studies on the rat thymectomized in adult life. Immunology (1965) 3.17
Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00
HETEROLOGOUS MOUSE ANTI-LYMPHOCYTE SERUM TO PROLONG SKIN HOMOGRAFTS. Surg Forum (1964) 2.78
Allograft survival: effect of antiserums to thymus glands and lymphocytes. Science (1965) 2.45
Effect of antilymphocytic serum on the survival of renal homotransplants in dogs. Transplantation (1966) 2.38
SEROTYPING FOR HOMOTRANSPLANTATION. VII. SELECTION OF KIDNEY DONORS FOR THIRTY-TWO RECIPIENTS. Ann N Y Acad Sci (1966) 2.25
Avenues of future research in homotransplantation of the liver with particular reference to hepatic supportive procedures, antilymphocyte serum, and tissue typing. Am J Surg (1966) 1.89
Effect of adult thymectomy on the recovery from immunological depression induced by anti-lymphocyte serum. Surg Forum (1965) 1.60
The effect of heterologous immune serum on canine renal homografts. Transplantation (1966) 1.52
VASCULAR AND OTHER CHANGES IN 200 CANINE RENAL HOMOTRANSPLANTS TREATED WITH IMMUNO-SUPPRESSIVE DRUGS. Lab Invest (1964) 1.44
Aggravation of hepatic lesions in mice by in vivo localization of immune complexes (Auer hepatitis). Am J Pathol (1965) 1.43
Evolution of liver transplantation. Hepatology (1982) 19.54
A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33
Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32
A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21
Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16
Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12
Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12
Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08
Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Clinical, microbiologic, neurologic and pathologic features. Am J Med (1967) 4.08
Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99
Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99
Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73
Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66
Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63
Hepatic Retransplantation. Transplant Proc (1985) 3.62
Transplantation of multiple abdominal viscera. JAMA (1989) 3.59
Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57
Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54
Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49
Cadaveric renal transplantation. An analysis of 65 cases. Lancet (1969) 3.48
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40
Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38
The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
Changes in blood coagulation. Arch Surg (1966) 3.22
Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18
Renal transplantation in baboons under FK 506. Surgery (1989) 3.17
Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg (1985) 3.17
Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16
Liver transplantation before 1 year of age. J Pediatr (1987) 3.15
In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc (1988) 3.15
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14
Fungal infections in liver transplant recipients. Transplantation (1985) 3.07
De novo malignant tumors in organ transplant recipients. Transplant Proc (1971) 3.03
Experience with 150 liver resections. Ann Surg (1983) 3.01
A multifactorial system for equitable selection of cadaver kidney recipients. JAMA (1987) 3.01
Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00
Death after transplantation; an analysis of sixty cases. Am J Med (1967) 2.99
Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98
Biliary tract complications in human orthotopic liver transplantation. Transplantation (1987) 2.95
Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95
Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev (1971) 2.94